DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.
Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study.
Chest 2016;
150 (04) 789-798
We do not assume any responsibility for the contents of the web pages of other providers.